Taft Foley III, an 18-year-old high school senior, co-founded Texas Mobile Medical Labs. Photo courtesy of Texas Mobile

An 18-year old high school senior from the Houston area mobilized his medical knowledge as one of the youngest EMTs in Texas and co-founded a mobile lab which can provide COVID-19 results in 15 minutes.

Texas Mobile Medical Labs was created to counteract testing delays that bogged down how quickly patients received results. The mobile lab currently operates in a van and a tent outside a community center in the Post Oak area for patients who prefer to come to them. For those that can't, the mobile lab can travel to any patient or business location for employee testing in the Houston area after they set up an appointment.

"This summer I become an EMT, training at the Texas EMS Academy in Corpus Christi," says Taft Foley III, co-founder of Texas Mobile Medical Labs. "When I got back to Houston I was asked to take a COVID-19 test, but I was met with a line that wrapped around the entire building and took two hours just to get inside."

According to Foley, that spurred him into finding a better way to get results to people quickly.

"I did my research and found a better alternative to increase testing and reduce waiting times," says Taft. "The antigen test works in 15 minutes, which makes them amenable to point-of-care use. That's when I really got the idea of going out to our patients for the test so that they don't have to leave home."

The tests are performed with a nasal swab, which then detects a viral protein in an actively infected person, giving accurate and fast results.

Antigens are molecules capable of stimulating an immune response. The SARS-CoV-2 that causes COVID-19 has several known antigens including its nucleocapsid phosphoprotein and spike glycoprotein, which are the visible protrusions on its surface.

Antigen tests reveal if a person is currently infected with a pathogen such as the SARS-CoV-2 virus. Once the infection is gone, the antigen disappears.

Although antigen tests typically have lower sensitivity than a traditional PCR test, that detects the virus through its genetic material, they provide tests rapidly and are relatively cheaper to produce.

"Getting this test to as many people as possible as fast as possible is essential," says Taft. "People need to know whether or not they need to stay home and if they're at risk of spreading the virus to others."

The results are sent to patients via text message or email, giving individuals peace of mind quickly if they are not infected and allowing those with COVID-19 to quarantine themselves and those they have exposed.

The test cost ranges from $100 to $150 for individuals, according to their website, depending on if testers would like to go to their tent location or take advantage of their mobile lab. While they currently do not accept insurance, most insurance companies will reimburse some or all of the cost of the test.

You can reach the Texas Mobile Medical lab at (936) 333-3333 if you have COVID-19 symptoms and would like to schedule an appointment for testing.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston healthtech startup raises $30M to scale surgical healing gel

fresh funding

Houston-based healthtech startup TYBR Health has raised a $30 million Series A round to scale its B3 GEL System, which helps protect tendons from scarring after surgery.

The round was led by Minneapolis-based Vensana Capital and Cleveland-based Mutual Capital Partners, with participation from Denver-based Neovate Capital Partners and existing investors, according to a news release from the company.

TYBR Health said it plans to use the funding to broaden the B3 GEL System's clinical applications, expand commercialization and conduct studies to evaluate its ability to protect tissue and improve healing outcomes.

"Surgeons are exceptionally good at the structural repair, but the biology that follows is what determines how it heals. That part of the equation has gone largely unaddressed ... There's a shift underway across surgical specialties, from focusing almost entirely on the mechanical repair to also weighing the biological conditions that repair needs to succeed," Tim Keane, co-founder and CEO of TYBR Health, said in the news release. "This financing lets us reach more surgeons and generate the clinical evidence to move that shift forward."

As part of the financing round, Greg Banker of Vensana Capital and Liz Todia Zambory of Mutual Capital Partners will join the TYBR board, alongside independent director Aaron Smith.

"TYBR Health is addressing a gap surgeons have lived with for a long time, with a product that fits the way they already work," Zambory, principal at Mutual Capital Partners, added in the release. "We're excited to co-lead this round and support the company's growth."

TYBR was founded in 2020 and originated from the TMCi’s Biodesign fellowship and participated in the TMC's Accelerator for HealthTech. Its B3 GEL System is a flowable extracellular matrix hydrogel designed to protect tendons, ligaments, muscles, and the surrounding soft tissue while they heal from orthopedic surgery. It received FDA 510(k) clearance last June and launched an Australian clinical trial in the fall.

The B3 GEL System has been used in hand, wrist, shoulder, foot and ankle, and sports medicine procedures since it launched, according to the company, and was first used in the clinical setting earlier this year by Dr. Tammam Hanna with Texas Tech University Health Sciences Center.

Houston space companies win NASA funding to build Mars exploration robots

mission to mars

Two Houston-area spacetech companies have landed a portion of a $17 million award from NASA to develop robots for exploring the surface of Mars, the agency announced this month.

Houston-based Inuitive Machines and Webster, Texas-based MEI Technologies, which does business as Aegis Aerospace, were among the seven companies selected to receive the funding from NASA's Science Transport and Robotic Innovation for Deployment and Exploration (STRIDE) initiative.

According to the release from NASA, the companies are tasked with creating "innovative mobility systems" that would allow future Mars missions to access more challenging terrain and difficult-to-reach regions of the planet, and to travel farther distances. NASA estimated that the work will begin this fall.

NASA solicited proposals for participants in the STRIDE initiative in January. The seven named companies are the first selected to participate in the program.

The additional five companies to receive STRIDE funding include:

"STRIDE demonstrates NASA’s commitment to strong public-private partnerships, allowing the agency to explore new approaches for Mars surface exploration while identifying key capability gaps and development needs for commercial systems that could operate and traverse realistic Martian environments," NASA shared in the announcement.

Last month, Intuitive Machines was awarded $148.3 million to deliver its Nova-C lander to the moon. The funding was part of $600 million the space agency awarded to three companies as part of its Moon Base Program and was Intuitive Machines' sixth task order under NASA's Commercial Lunar Payload Services (CLPS) program. Astrobotic was also one of the companies to land funding for the Moon Base program, as well as Austin-based Firefly Aerospace.

Around the same time, Firefly Aerospace was awarded a $13 million subcontract from NASA’s Jet Propulsion Laboratory to develop technology for NASA’s SkyFall mission to Mars. The mission aims to deploy three Mars helicopters to "perform science and demonstrate airborne subsurface mapping and resource prospecting on the planet." Read more here.